Limitations in Controlling Risk for Recurrence After Curative Surgery for Advanced Gastric Cancer Are Now Well-Explained by Molecular-Based Mechanisms-Reference-Cited by-同舟云学术

Limitations in Controlling Risk for Recurrence After Curative Surgery for Advanced Gastric Cancer Are Now Well-Explained by Molecular-Based Mechanisms

Published:2001-09 Issue:8 Volume:8 Page:620-621
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Roukos Dimitrios H.,Kappas Aggelos M.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10434-001-0620-5.pdf

Reference13 articles.

1. Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev 2000;26:243?255.

2. Bonnenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908?914.

3. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resection for gastric cancer: long-term results of the MRC randomised surgical trial. Surgical co-operation group. Br J Cancer 1999;79:1522?1530.

4. Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric-cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients. Br J Cancer 2001 (in press).

5. Fujii M, Sasaki J, Nakajima T. State of the art in the treatment of gastric cancer: from the 71st Japanese gastric cancer congress. Gastric Cancer 1999;2:151?157.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors for gastrectomy in elderly patients with gastric cancer;World Journal of Surgical Oncology;2017-03-11

2. Prognostic Significance of Complications after Curative Surgery for Gastric Cancer;Annals of Surgical Oncology;2013-11-20

3. Identification of hsa-miR-335 as a Prognostic Signature in Gastric Cancer;PLoS ONE;2012-07-03

4. Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection;Annals of Oncology;2011-10

5. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer;Gastric Cancer;2008-06